Carboplatin pharmacokinetics in young children with brain tumors Margaret E. TondaRichard L. HeidemanJ. H. Rodman ORIGINAL ARTICLE Pages: 395 - 400
Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer T. IchikuraS. TomimatsuS. Tamakuma ORIGINAL ARTICLE Pages: 401 - 405
Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs B. S. AnderssonTara SadeghiDavid Murray ORIGINAL ARTICLE Pages: 406 - 416
Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and Adriamycin in tumor-bearing mice H. ShinkaiHideaki TakahashiTomonobu Tokiwa ORIGINAL ARTICLE Pages: 417 - 424
Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients H. KastrissiosNelson J. ChaoTerrence F. Blaschke ORIGINAL ARTICLE Pages: 425 - 430
Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120 M. I. WaltonP. GoddardK. R. Harrap ORIGINAL ARTICLE Pages: 431 - 438
Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin L. P. RivoryKathryn M. AventSusan M. Pond ORIGINAL ARTICLE Pages: 439 - 445
Potentiation of antitumor and antimetastatic activities of adriamycin by a novel N-alkylated dihydropyridine, AC394, and its enantiomers in colon cancer-bearing mice K. OhishiYoshihiro MorinagaTakashi Tsuruo ORIGINAL ARTICLE Pages: 446 - 452
Identification and antitumor activity of a reduction product in the murine metabolism of pyrazoloacridine (NSC-366140) Eduardo PalominoB. FosterL. Baker ORIGINAL ARTICLE Pages: 453 - 458
Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer F. RobertShande ChenRichard H. Wheeler ORIGINAL ARTILCE Pages: 459 - 465
Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma Winnie YeoT. W. T. LeungPhilip J. Johnson ORIGINAL ARTICLE Pages: 466 - 470
Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens G. BarrenetxeaJosé SchneiderFrancisco Javier RodrÃguez-Escuderoo CLINICAL TRIAL REPORT Pages: 471 - 475
Comparison of idarubicin and daunorubicin and their main metabolites regarding intracellular uptake and effect on sensitive and multidrug-resistant HL60 cells U. TidefeltMalin PrenkertChrister Paul SHORT COMMUNICATION Pages: 476 - 480
Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats M. LemaireArmin BruelisauerHitoshi Sato SHORT COMMUNICATION Pages: 481 - 486